RE: I'll get my coat.23 Feb 2021 18:15
The use of Camelid antibodies in the French test seems strikingly similar to the use of Affimers to bind to spike proteins, except that Affimers may be somewhat easier to fine tune to new variants.
I am trying to remember whether DVRG uses a change in optical properties or a change in electrical properties when the Affimers latch onto spike proteins. Can someone help me here?
Lots of claims, but what, actually, are the S & S?
Looks like a clever test idea, but, for poorer parts of the world, or home testing, is the use of electronics the best way forward?
Some points, looking at Google Translate's translation from the eurosante article, which is linked to in the Guardian article:
* The test uses 'Nasopharyngeal biological samples from patients'.
* 'percentage of positive agreement (PPA) of 88% and a percentage 88% negative agreement (NPA) on clinical samples, compared to a conventional RT-PCR test.'
Hmm, neither of the previous two points sound too good to me.
Test, test, test